Scinai Immunotherapeutics Ltd.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filer
State of Incorporation
Israel
Business Address
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, L3, 00000
Mailing Address
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, L3, 00000
Phone
972-8-9302529
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025 FY
$1.31M
Revenue
$13.45M
Total Assets
$9.98M
Stockholders' Equity
$4.87M
Cash & Equivalents
$0.00
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 20-F Foreign company annual report | April 1, 2026 | View on SEC |
| 3 Initial insider ownership report | March 26, 2026 | View on SEC |
| 6-K Foreign company current report | March 23, 2026 | View on SEC |
| 6-K Foreign company current report | March 19, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
Annual Reports
20-F
April 1, 2026
- Dual-engine business model combining proprietary NanoAbs drug development with CDMO service revenue.
- Lead project SCIN-11 shows potential in treating inflammation and autoimmune conditions.
Related Companies
Companies in the same industry (SIC: 2836)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
GRML
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Innate Pharma SA
IPHA
Biological Products, (No Diagnostic Substances)
Black Hawk Acquisition Corp
BKHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.